119 results
Page 2 of 6
424B5
ywc4trh7
28 May 20
Prospectus supplement for primary offering
12:00pm
6-K
EX-99
cp53udxg
27 Mar 19
BioLineRx Announces Successful Engraftment Data
7:01am
6-K
EX-99
81r24ih
7 Feb 19
As Representative of the several Underwriters
12:00pm
424B5
i4inv6
5 Feb 19
Prospectus supplement for primary offering
5:12pm
424B5
ncr941i8g6
4 Feb 19
Prospectus supplement for primary offering
5:52pm
6-K
EX-99.1
axqfnw6
4 Feb 19
Current report (foreign)
4:30pm
6-K
EX-99
pfm w6l0ngj4xz1ea
4 Feb 19
BioLineRx Receives Orphan Drug Designation from the FDA
7:00am
6-K
EX-99
uablvs20xt a58oxlln
11 Dec 18
BioLineRx Announces Initiation of Triple Combination Arm of
7:00am
6-K
EX-99
9sdhy7
22 Oct 18
Current report (foreign)
7:00am
6-K
EX-99
9srzezbp1w 8lybd899x
19 Oct 18
BioLineRx Presents Top-Line Results from
7:00am
6-K
EX-10.3
2hw40m3dvo
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am
6-K
EX-99.1
d97 mdesd9a8ux0
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am
6-K
EX-99
5ovqci65 hwhaw11rmql
7 Aug 18
BioLineRx Announces Positive Results of Lead-in Period
7:00am
6-K
EX-99
0bm9y0zrf cue
18 Jun 18
BioLineRx Presents New Overall Survival Data from
7:00am
6-K
EX-99
bznbhc4t76uon
17 May 18
BioLineRx to Present Overall Survival Data at EHA from
9:12am
6-K
EX-99
4tezrr
17 May 18
BioLineRx Reports Results of Phase 2 Study
8:57am
6-K
EX-99
mppqegvzzidjmmmp
16 May 18
BioLineRx Announces Grant of European Patent
6:58am